Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 4
1981 4
1982 4
1983 4
1984 7
1985 3
1986 3
1987 2
1989 1
1990 4
1991 1
1992 7
1993 2
1994 1
1997 1
2002 2
2003 1
2004 3
2005 2
2006 5
2007 2
2008 4
2009 1
2010 3
2011 4
2012 4
2013 2
2014 1
2015 1
2016 2
2017 3
2018 4
2019 4
2020 1
2021 6
2022 2
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Results by year
Filters applied: . Clear all
Page 1
Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
Al-Saffar A, Lennernäs H, Hellström PM. Al-Saffar A, et al. Neurogastroenterol Motil. 2019 Nov;31(11):e13617. doi: 10.1111/nmo.13617. Epub 2019 May 2. Neurogastroenterol Motil. 2019. PMID: 31050085 Review.
Regulatory authorities issued restrictions and recommendations regarding long-term use of the drug at oral doses exceeding 10 mg 3-4 times daily because of the risk for development of tardive dyskinesia. The aim of our study was to review mechanism(s) of action and …
Regulatory authorities issued restrictions and recommendations regarding long-term use of the drug at oral doses exceeding 10 mg 3-4 times d …
Gastroparesis.
Cangemi DJ, Lacy BE. Cangemi DJ, et al. Curr Opin Gastroenterol. 2021 Nov 1;37(6):596-601. doi: 10.1097/MOG.0000000000000782. Curr Opin Gastroenterol. 2021. PMID: 34560721 Review.
There is increasing sentiment that gastroparesis should be considered a part of the same spectrum of gastric neuromuscular disorders. The risk of tardive dyskinesia with metoclopramide has likely been significantly overestimated historically. ...SUMMARY: Alte …
There is increasing sentiment that gastroparesis should be considered a part of the same spectrum of gastric neuromuscular disorders. The ri …
Review article: metoclopramide and tardive dyskinesia.
Rao AS, Camilleri M. Rao AS, et al. Aliment Pharmacol Ther. 2010 Jan;31(1):11-9. doi: 10.1111/j.1365-2036.2009.04189.x. Aliment Pharmacol Ther. 2010. PMID: 19886950 Free article. Review.
In 2009, the FDA issued a black box warning regarding long-term or high-dose use of this medication because of the risk of developing tardive dyskinesia. AIMS: To review the mechanism of action and pharmacokinetic properties of metoclopramide, the risk of …
In 2009, the FDA issued a black box warning regarding long-term or high-dose use of this medication because of the risk of developing tar …
Metoclopramide and tardive dyskinesia in the elderly.
Orme ML, Tallis RC. Orme ML, et al. Br Med J (Clin Res Ed). 1984 Aug 18;289(6442):397-8. doi: 10.1136/bmj.289.6442.397. Br Med J (Clin Res Ed). 1984. PMID: 6432115 Free PMC article. No abstract available.
Metoclopramide for the treatment of diabetic gastroparesis.
Shakhatreh M, Jehangir A, Malik Z, Parkman HP. Shakhatreh M, et al. Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):711-721. doi: 10.1080/17474124.2019.1645594. Epub 2019 Jul 30. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31314613 Review.
Metoclopramide side effects, mostly related to its ability to cross the blood-brain barrier, include drowsiness, restlessness, hyperprolactinemia, and tardive dyskinesia (TD), a movement disorder that may be irreversible. Expert opinion: Metoclopramide …
Metoclopramide side effects, mostly related to its ability to cross the blood-brain barrier, include drowsiness, restlessness, hyperp …
Tardive dyskinesia and metoclopramide.
Stanley M, Rotrosen J, Lautin A, Wazer D, Gershon S. Stanley M, et al. Lancet. 1979 Dec 1;2(8153):1190. doi: 10.1016/s0140-6736(79)92417-6. Lancet. 1979. PMID: 91920 No abstract available.
Metoclopramide and tardive dyskinesia.
Sewell DD, Kodsi AB, Caligiuri MP, Jeste DV. Sewell DD, et al. Biol Psychiatry. 1994 Nov 1;36(9):630-2. doi: 10.1016/0006-3223(94)90077-9. Biol Psychiatry. 1994. PMID: 7833431 No abstract available.
Tardive Dyskinesia in Older Persons Taking Antipsychotics.
Citrome L, Isaacson SH, Larson D, Kremens D. Citrome L, et al. Neuropsychiatr Dis Treat. 2021 Oct 14;17:3127-3134. doi: 10.2147/NDT.S328301. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34703232 Free PMC article. Review.
Tardive dyskinesia (TD) is a hyperkinetic movement disorder caused by the use of dopamine receptor-blocking agents (DRBAs), a category of medications that includes first- and second-generation antipsychotics (APs) and agents such as metoclopramide that are us …
Tardive dyskinesia (TD) is a hyperkinetic movement disorder caused by the use of dopamine receptor-blocking agents (DRBAs), a …
Tardive dyskinesia.
Jeste DV, Caligiuri MP. Jeste DV, et al. Schizophr Bull. 1993;19(2):303-15. doi: 10.1093/schbul/19.2.303. Schizophr Bull. 1993. PMID: 8100643 Review.
Neuroleptic-induced tardive dyskinesia (TD) continues to be a serious problem in the psychopharmacology of schizophrenia. ...Other likely risk factors include female gender, mood disorders, "organic" brain dysfunction or damage, diabetes mellitus, and early extrapyr …
Neuroleptic-induced tardive dyskinesia (TD) continues to be a serious problem in the psychopharmacology of schizophrenia. ...O …
Metoclopramide and haloperidol in tardive dyskinesia.
Bateman DN, Dutta DK, McClelland HA, Rawlins MD. Bateman DN, et al. Br J Psychiatry. 1979 Dec;135:505-8. doi: 10.1192/bjp.135.6.505. Br J Psychiatry. 1979. PMID: 43755 Clinical Trial.
The effect of single intravenous doses of metoclopramide (10 mg, 20 mg and 40 mg) and haloperidol (5 mg and 10 mg) have been compared to placebo (saline) in a double blind randomised study in 8 patients with tardive dyskinesia secondary to neuroleptic therapy …
The effect of single intravenous doses of metoclopramide (10 mg, 20 mg and 40 mg) and haloperidol (5 mg and 10 mg) have been compared …
102 results